Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid in Healthy Volunteers and Trauma Patients
NCT02872428Phase 1Terminated
- Start
- Nov 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of valproic acid in hemorrhagic shock and psychological trauma (2 arms). Primary endpoint: Dose limiting toxicity at 6 weeks. Started Nov 2016; status: terminated.
02
Drugs
valproic acid
03
Conditions
hemorrhagic shockpsychological trauma
Beyond the preview
Go deeper on NCT02872428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872428.